Pfizer Says Experimental Covid Pill Cuts Risk Hospitalization Death Study - atlasoceanvoyages News
Pfizer said nov. 5 its experimental covid-19 antiviral pill reduced the risk of hospitalization or death by 89 percent in clinical trials, and the drugmaker plans to file for Pfizer's experimental pill to treat covid-19 is almost 90% effective - that's according to an interim analysis.
Said friday that its experimental antiviral pill for covid-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined.
๐ Related Articles You Might Like:
Kevin Bacon Kyra Sedgwick Cover Miley Cyrus Song Flowers Halle Berry Shares Video Her Falling At Charity Event Czech Republic Soccer Player Jakub Jankto Comes Out As Gay๐ธ Image Gallery
๐ Continue Reading:
Sarah Paulson Mobile Home Malibu See Inside Hugh Hudson Director Of Chariots Of Fire Dead At 86